Screener
Ligand Pharmaceuticals LGND Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Ligand Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886163-26-000044
FAQ
- What is Ligand Pharmaceuticals's operating lease ROU assets?
- Ligand Pharmaceuticals (LGND) reported operating lease ROU assets of $6.44M in Q2 2026.
- How has Ligand Pharmaceuticals's operating lease ROU assets changed year-over-year?
- Ligand Pharmaceuticals's operating lease ROU assets decreased by 19.4% year-over-year, from $7.99M to $6.44M.
- What is the long-term trend for Ligand Pharmaceuticals's operating lease ROU assets?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's operating lease ROU assets has grown at a 0.9% compound annual growth rate (CAGR), from $6.89M to $7.22M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Ligand Pharmaceuticals's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude